Literature DB >> 2201210

Modulation of transmembrane potential of isolated cardiac myocytes by insulin and isoproterenol.

J Eckel1, H Reinauer.   

Abstract

Isolated muscle cells from adult rat heart have been used to study the effects of insulin and catecholamines on transmembrane potential by following triphenylmethylphosphonium cation uptake. Insulin was found to hyperpolarize the cells with a maximal effect of 3.2 +/- 0.7 mV (n = 4) at an insulin concentration of 3 x 10(-9) mol/l. This insulin action was fully antagonized by isoproterenol (10(-5) mol/l), which depolarized the cardiocytes in a dose-dependent fashion with a maximal effect of 9.5 +/- 2.2 mV. Treatment of cardiocytes with ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid or CsCl resulted in a total loss of insulin action, whereas isoproterenol action was not affected. Cardiac myocytes from streptozotocin diabetic rats exhibited an unaltered hyperpolarization by insulin within the physiological concentration range. Isoproterenol now induced a biphasic response with a significant hyperpolarization at low doses and a decreased depolarization at maximal concentrations. In conclusion, 1) hormonal modulation of cardiac myocyte membrane potentials involves hyperpolarization by insulin and depolarization by beta-agonists, 2) insulin action appears to be related to an increased potassium conductance and may be antagonized by beta-stimulation, and 3) membrane potential modulation may be profoundly altered in the diabetic state.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201210     DOI: 10.1152/ajpheart.1990.259.2.H554

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  G-protein-mediated regulation of the insulin-responsive glucose transporter in isolated cardiac myocytes.

Authors:  J Eckel; E Gerlach-Eskuchen; H Reinauer
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Insulin induced translocation of Na+/K+ -ATPase is decreased in the heart of streptozotocin diabetic rats.

Authors:  Klara Rosta; Eszter Tulassay; Anna Enzsoly; Katalin Ronai; Ambrus Szantho; Tamas Pandics; Andrea Fekete; Peter Mandl; Agota Ver
Journal:  Acta Pharmacol Sin       Date:  2009-11-16       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.